CreakyJoints Presents Five Posters at 2016 ACR/AHRP Annual Meeting
UPPER NYACK, N.Y.–(BUSINESS WIRE)– CreakyJoints®,
the go-to source for more than 100,000 arthritis patients and their
families world-wide who are seeking education, support, advocacy, and
patient-centered research, today announced the forthcoming publication
of “A Patient’s Guide to Living with Rheumatoid Arthritis.” During the
2016 ACR/AHRP Annual Meeting, taking place in Washington, D.C., November
11-16, 2016, CreakyJoints will preview the guidelines’ Patient Charter,
which was developed and endorsed by CreakyJoints’ national Patient
Council as well as select rheumatologists, who informed the full-length
patient guidelines to be published during the first quarter of 2017. “A
Patient’s Guide to Living with Rheumatoid Arthritis” is the first in a
planned series of patient-friendly guidelines that will cover additional
related conditions such as psoriatic arthritis, ankylosing spondylitis,
and others.
“The diagnosis of a lifelong chronic disease like RA can be
overwhelming, but it is vital that patients be at the center of
decisions about their treatment and management strategy,” stated Seth
Ginsberg, President and Co-Founder of CreakyJoints. “The Patient Charter
spells out the eight tenets that the arthritis community should expect
and demand from the healthcare they receive to better ensure that we
patients are at the center of decision-making. Coming soon, for the
first time, patients have a detailed, straight-forward guide to help
them navigate and understand their options, including tips about
applying health knowledge so that they can feel more in control of their
journey with RA.”
Similar in spirit to the current RA Guidelines developed by the American
College of Rheumatology for medical professionals, the new patient
guidelines are being written by a dedicated panel that included
patients, rheumatologists, and CreakyJoints’ staff writers. As
demonstrated by a CreakyJoints study published in November 2015 in Arthritis
Care & Research, patients are ready and able to evaluate
existing scientific evidence and this capability informed these new
guidelines. The patient guidelines are being written to be understood
and referred to by patients seeking guidance for how to speak to their
rheumatologist or other health professionals about their treatment plan,
how to ask questions of their insurance company regarding coverage, and
best practices for meeting or communicating with local legislators to
advocate for patient-friendly health care laws.
“More than ever before, patients across all disease categories can
access a mountain of information simply by asking ‘Dr. Google,’ but the
risk is that it can be challenging to identify credible sources and to
assess what constitutes good medical advice,” stated Dr. Jonathan Krant,
MD, Medical Director of CreakyJoints and Section Chief of Rheumatology
at Adirondack Health Systems in Saranac Lake, N.Y. “These guidelines
will help patients decode their treatment options and provide tools to
help them ask the questions that are important to them as they decide
their management strategy.”
“A Patient’s Guide to Living with Rheumatoid Arthritis” is under review
by Dr. Krant; Dr. Madelaine Feldman, MD, Rheumatology Alliance of
Louisiana and Coalition of State Rheumatology Organization executive
committee member; and Dr. Sarah Doaty, MD, Rheumatologist with the
Alaska Native Tribal Health Consortium. A national Patient Council
convened by CreakyJoints in early October provided additional input and
direction for the Patient Charter and patient guidelines. The Patient
Charter is available on the CreakyJoints website, https://creakyjoints.org/patientcharter/.
CreakyJoints Presents Data at ACR/AHRP Annual Meeting
Sunday,
November 13, CreakyJoints presented five posters at the 2016 ACR/AHRP
Annual Meeting in Washington, D.C. Dr. W. Benjamin Nowell, Ph.D.,
Director of Patient-Centered Research for CreakyJoints presented a
poster in partnership with Dr. Liana Fraenkel, MD, MPH, Yale University
School of Medicine, titled “Development of RA Patient Preference
Phenotypes.”
When RA treatment escalation is being considered because methotrexate or
other monotherapy has proved inadequate, it can be challenging for a
patient to understand and evaluate the pros and cons of different
medication options presented by a physician. In such cases, patients are
often curious about the choices that other patients like them have made.
This study surveyed 1,100 RA patients to categorize how they weigh
differences among medications’ various features (effectiveness, mode of
administration, risk factors, cost, and other factors) to make treatment
decisions. Five major patient preference phenotypes were identified that
may support the decision-making process for physicians and patients.
Survey respondents were identified via CreakyJoints.
“During a short office visit, physicians and patients may benefit from a
common tool to facilitate better communication. Patient preference
phenotypes may help rheumatologists understand their patients’ values
better, thereby making conversations about treatments more meaningful,”
stated Dr. Nowell. “We strive to keep patients at the center of all
research conducted by CreakyJoints. This study and others we presented
at the ACR meeting, along with the new RA patient guidelines, align with
our mission to improve patients’ health outcomes, overall health care
experience through shared decision-making, and by listening to what
patients have to say.”
Data for two other posters were collected via ArthritisPower™, the first
patient-centered, patient-directed arthritis research registry developed
by CreakyJoints in partnership with the University of Alabama at
Birmingham and part of the PCORnet network of research registries. One
final poster highlighted the decisions that patients think are most
important when considering hip or knee joint replacement. These findings
emerged from a CreakyJoints pre-research engagement project titled
“BeTTER SAID,” funded by the Patient Centered Outcomes Research
Institute (PCORI). BeTTER SAID (Bringing Stakeholders Together
for Engagement in Research for the Selection of
Arthroplasty Implant Devices) aims to develop a cohort of patients,
patient advocates, researchers, physicians/surgeons, and health system
leaders examining strategies to improve joint replacement device safety
and effectiveness.
Posters presented at the 2016 ACR/AHRP Annual Meeting included:
-
Development
of RA Patient Preference Phenotypes
(Abstract #516) -
Patient
Decisions Related to Hip and Knee Arthroplasty and the Factors
Influencing Them (Abstract
#110) -
What
Factors Relate to Patients Contributing Longitudinal Data Using
Smartphone Technology? Findings from RA Patients Participating in
ArthritisPower Registry
(Abstract #8) -
Optimizing
the Efficiency of Patient Data Capture Using Smartphone Technology:
Evaluation of the Correlation Between PROMIS Instruments for PRO Data
Capture (Abstract #86) -
People
with Rheumatoid Arthritis Recruited from an Online Patient Community
May Differ from Clinical Populations in Symptoms and Impacts
(Abstract #103)
About ArthritisPower
ArthritisPower is
the first ever patient-led, patient-centered research registry for
arthritis, bone, and inflammatory skin conditions. The ArthritisPower
mobile and desktop application allows patients to track, measure, and
share their symptoms and treatments outcomes while simultaneously
participating in arthritis research via informed consent. ArthritisPower
Patient Governors serve as gatekeepers for researchers seeking to access
registry data or solicit the community to participate in unique,
voluntary studies and arthritis research. To learn more and join
ArthritisPower, visit www.ArthritisPower.org.
About CreakyJoints
CreakyJoints®,
now in its 17th year, has evolved into the go-to source for
more than 100,000 arthritis patients and their families world-wide who
are seeking education, support, advocacy, and patient-centered research.
Co-founded in 1999 by arthritis patient Seth Ginsberg and social
entrepreneur Louis Tharp, CreakyJoints is part of the Global
Healthy Living Foundation, whose mission is to improve the quality
of life for people with chronic illness. For more information and to
become a member (for free), visit www.CreakyJoints.org.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161114005128/en/
Source: CreakyJoints
Cet article First Ever Rheumatoid Arthritis Patient Guidelines Announced by
CreakyJoints est apparu en premier sur EEI-BIOTECHFINANCES.